Evolution of rituximab use over time in moderate-to-severe pemphigus: A two-centre retrospective study

Ann Dermatol Venereol. 2024 Jun;151(2):103265. doi: 10.1016/j.annder.2024.103265. Epub 2024 Mar 28.

Authors

M Hazard¹, C Bedane², O Ducharme³, P Bernard⁴, A-L Pham-Ledard³

Affiliations

¹ Dermatology Department, Limoges University Hospital, Limoges, France. Electronic address: [email protected].
² Dermatology Department, Dijon University Hospital, Dijon, France.
³ Dermatology Department, Bordeaux University Hospital, Bordeaux, France.
⁴ Dermatology Department, Limoges University Hospital, Limoges, France.

PMID: 38552270
DOI: 10.1016/j.annder.2024.103265

No abstract available

Publication types

Multicenter Study
Letter

MeSH terms

Adult
Aged
Female
Humans
Immunologic Factors* / therapeutic use
Male
Middle Aged
Pemphigus* / drug therapy
Retrospective Studies
Rituximab* / therapeutic use
Severity of Illness Index

Substances

Rituximab
Immunologic Factors